• Select a Category Acid/Base/Electrolytes\nAKI\nArteriovenous Fistula\nArteriovenous Graft\nCatheter\nCKD\nCRRT\nCystic Diseases\nDiabetic Nephropathy\nEnd-Stage Renal Disease\nGeneral Nephrology\nGlomerulonephritides\nGlomerulonephritides\nHemodialysis\nHenderson-Hasselbach\nHome Hemodialysis\nHypertension\nImmunosuppression\nInfectious Diseases\nInternists Guide To...\nNephrolithiasis\nNutrition\nPeritoneal Dialysis\nPharma Resources\nPotassium Homeostasis\nPre-Surgical Issues\nPregnancy\nRenal Replacement\nSodium Homeostasis\nStrong Ion Theory\nTransplantation\nVascular Access\nWater\n

• Introduction

  The Nephrology On-Demand educational experience includes:

  • • High-def teaching videos on YouTube
  • • Weekly updates of our teaching content on Twitter and Facebook
  • • Self-assessment tools in the form of Crossword puzzles
  • • Histopathology tutorials
  • • Creative writing in the form of Perspectives
  • • Blogs of popular scientific meetings
  • • Interesting Internal Medicine Grand Rounds presentations
  • • Q & A sessions with our Discussion Board

  

  Registration

  Register with Nephrology On-Demand and receive:

  1. total access to all of NOD's teaching resources,

  2. advanced notification of new NOD developments, and

  3. lifetime free access to all future NOD educational services/products

  

  Curious? Scan (or click) me to sign up

   

  HON Code

  This website is certified by the Health On the Net Foundation for accuracy and trustworthiness.

  More Press and Publications information

  Publications

  The number of scientific publications from the editors of Nephrology On-Demand

  14 16

  More Press and Publications information

  

  Ads

  The Number of Ads on this Website

  0

  More Funding and Sponsorship information

  

  Funding

  The amount of funding ($) that NOD has solicited from external sources, pharmaceutical companies, and users like you

  0

  More Funding and Sponsorship information

  

This randomized controlled trial addresses the question of whether aggressive blood pressure control (systolic blood pressures lower than 120 mm Hg) has a beneficial effect on cardiovascular outcomes compared to standard of care (systolic blood pressures lower than 140 mm Hg).

************************************** Time Required (estimated): 35 minutes Title: Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus Citation: New England Journal of Medicine 2010; doi 10.1056/NEJMoa1001286 Date Created: 2010 Revisions: None Indicated Disclaimers: Indicated on page 10 of the article Resource Type: Text Other: Recommended by Paul Bolin, MD Recommend to a Colleague/Friend **************************************	Was this teaching resource valuable? Scroll down and complete our 6-point Transparent Peer Evaluation.

---

---

Transparent Peer Review
Your reviews are anonymous

To learn more about our 6-point transparent peer review system, click here

---

---

Comments

• Recent Posts

  • Paraproteinemias and the Kidney June 15, 2013
  • Childhood Nephrotic Syndrome June 14, 2013
  • Cilastatin in the therapy of Cisplatin Nephrotoxicity May 31, 2013
  • Dual Renin-Angiotensin-Aldosterone Blockade April 30, 2013
  • Tolvaptan in the Treatment of Adult Polycystic Kidney Disease: TEMPO 3:4 Trial April 16, 2013
  • Getting Ready for JNC 8: Review of Antecedent Hypertension Trials April 14, 2013
  • Peritoneal Dialysis for the Internist February 14, 2013
  • Tuberous Sclerosis Complex – Updates February 1, 2013
  • International Conference on Dialysis – 2013 January 23, 2013
  • International Pediatric Nephrology Fellows Conference January 22, 2013